Nataliya Uboha, MD, PhD, associate professor, Hematology, Medical Oncology and Palliative Care, has led a promising phase II clinical trial at UW Carbone Cancer Center that uses modified T-cell therapy to fight cancer—the first such treatment used on a solid tumor patient at Carbone.

“It really is one of the most exciting areas of research in solid tumors,” Uboha says of T-cell therapy. “We have used this type of technology to treat liquid tumors, like lymphomas, leukemias, hematologic malignancies for a while, but these treatments haven’t crossed over into the solid tumor space until the last few years.”

Dr. Uboha’s efforts are assisted by Peiman Hematti, MD, professor, Hematology, Medical Oncology and Palliative Care, and director of the Bone Marrow Collection, Apheresis and Clinical Hematopoietic Cell Processing Center at UW Health.

Read the full story at UW Health.

Banner: Drs. Uboha (left) and Hematti (right) with their patient, Steve Larson of Iowa City, Iowa, during his first infusion treatment. Photo was provided by the patient.